Journal articleBiomed Rep2023
Gemcitabine‑fucoxanthin combination in human pancreatic cancer cells.
- Journal
- Biomed Rep
- Published
- 1 June 2023
- Citations
- 5
- Type
- Article
- License
- cc by-nc-nd
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract cc by-nc-nd
Gemcitabine is a chemotherapeutic agent for pancreatic cancer treatment. It has also been demonstrated to inhibit human pancreatic cancer cell lines, MIA PaCa-2 and PANC-1. … Excerpt only: this text is the publisher’s. Read it in full at the source.